Dr Jill Hunter Dr Jacqueline Butterworth Helene Sellier Dr Nicola Hannaway Dr Saimir Luli et al. | Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance | 2022 |
|
Yonggang He Joshua Paulin Tarry Mavimba Christine Hayes Dr Andrew Knight et al. | A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice | 2018 |
|
Dr Andrew Knight
| B-cell acquisition of antigen: Sensing the surface | 2015 |
|
Dr Marzena Ciechomska Dr Caroline Wilson Achilleas FLOUDAS Emeritus Professor Drew Rowan Professor John Robinson et al. | Antigen-specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD4+ T-cell activation | 2014 |
|
Achilleas FLOUDAS Dr Laura Jopson Dacia Jones Dr Andrew Knight Dr Jeremy Palmer et al. | Altered B cell populations and cytokine production in primary biliary cirrhosis | 2013 |
|
Dominic Hine Ariel Pradipta Professor Jeffrey Pearson Professor John Robinson Dr Andrew Knight et al. | Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4+T helper type 1 subset differentiation | 2012 |
|
Dr Marzena Ciechomska Dr Caroline Wilson Emeritus Professor Drew Rowan Professor John Robinson Dr Andrew Knight et al. | Antigen-specific B cells can acquire and present the rheumatoid arthritis candidate autoantigen aggrecan from a non-internalisable surface | 2011 |
|
Dr Marzena Ciechomska Professor Thomas Lennard Emeritus Professor John Kirby Dr Andrew Knight
| B lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cells | 2011 |
|
Dr Jeremy Palmer Dr Andrew Knight Professor Kevin Marchbank
| A novel chimeric antigen hC3d-TTCF-hC4BP interacts with mCR2 allowing extensive testing as a novel adjuvant using murine models | 2010 |
|
Dr Marzena Ciechomska Dr Caroline Wilson Emeritus Professor Drew Rowan Professor John Robinson Dr Andrew Knight et al. | Examination of the ability of autoreactive B cells to acquire and present the rheumatoid arthritis candidate autoantigen, aggrecan, from a non-internalizable surface | 2010 |
|
Professor John Robinson Dr Andrew Knight
| The role of B cells as antigen presenting cells in an animal model of rheumatoid arthritis | 2010 |
|
Dr Isabel Pappworth Christine Hayes Dr Andrew Knight Professor Kevin Marchbank
| The role of complement in the formation of B regulatory cells | 2010 |
|
Dr Caroline Wilson Professor John Robinson Dr Andrew Knight
| Efficient processing and presentation of the Rheumatoid Arthritis candidate autoantigen aggrecan, by antigen-specific B cells | 2009 |
|
Professor John Robinson Dr Andrew Knight
| A comparison of autoantigen processing by B cells, macrophages and dendritic cells | 2008 |
|
Dr Andrew Knight
| Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain | 2008 |
|
Dr Andrew Knight
| Regulated release of B cell-derived exosomes: Do differences in exosome release provide insight into different APC function for B cells and DC? | 2008 |
|
Dr Marzena Ciechomska Professor Thomas Lennard Emeritus Professor John Kirby Dr Andrew Knight
| The role of B cells in the induction of anti-tumour immunity | 2008 |
|
Dr Andrew Knight
| Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells | 2006 |
|
Dr Andrew Knight
| Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system | 2005 |
|
Dr Andrew Knight
| Distinct Sequences in the Cytoplasmic Domain of Complement Receptor 2 Are Involved in Antigen Internalization and Presentation | 2004 |
|
Dr Andrew Knight
| Lowering the affinity between antigen and the B cell receptor can enhance antigen presentation | 2004 |
|